Severe COVID-19 infection associated with endothelial activation

Thromb Res. 2020 Jun:190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Antiphospholipid / blood
  • Anticoagulants / therapeutic use
  • Betacoronavirus / isolation & purification
  • Blood Coagulation / drug effects
  • COVID-19
  • Coronavirus Infections / blood*
  • Coronavirus Infections / complications
  • Coronavirus Infections / pathology
  • Coronavirus Infections / therapy*
  • Dalteparin / therapeutic use
  • Endothelium / drug effects
  • Endothelium / pathology*
  • Factor VIII / analysis
  • Fibrin Fibrinogen Degradation Products / analysis
  • Heparin / therapeutic use
  • Humans
  • Immunoglobulin M / blood
  • Intensive Care Units
  • Male
  • Pandemics
  • Pneumonia, Viral / blood*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / pathology
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2
  • von Willebrand Factor / analysis

Substances

  • Antibodies, Antiphospholipid
  • Anticoagulants
  • Fibrin Fibrinogen Degradation Products
  • Immunoglobulin M
  • fibrin fragment D
  • von Willebrand Factor
  • Factor VIII
  • Heparin
  • Dalteparin